Christoph Bode
Bode, Christoph
Bode, Christoph, 1955-....
Bode, Christoph, Dr.
VIAF ID: 3686320 (Personal)
Permalink: http://viaf.org/viaf/3686320
Preferred Forms
- 100 1 _ ‡a Bode, Christoph
- 100 1 _ ‡a Bode, Christoph
- 100 1 _ ‡a Bode, Christoph, ‡c Dr.
-
- 100 1 _ ‡a Bode, Christoph, ‡d 1955-....
- 100 0 _ ‡a Christoph Bode
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
Case report : Lymphohistiocytic Myocarditis with severe cardiogenic shock requiring mechanical cardiocirculatory support in multisystem inflammatory syndrome following SARS-CoV-2 infection | |
Dual antiplatelet therapy (DAPT) versus no antiplatelet therapy and incidence of major bleeding in patients on venoarterial extracorporeal membrane oxygenation | |
Fibrinolytics and antifibrinolytics | |
Gene expression in immortalized versus primary isolated cardiac endothelial cells | |
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice | |
impact of transcatheter aortic valve implantation planning and procedure on acute and chronic renal failure | |
In-hospital outcomes of patients undergoing concomitant aortic and mitral valve replacement in Germany | |
Incidence of barotrauma in patients with COVID-19 pneumonia during prolonged invasive mechanical ventilation - a case-control study | |
Influence of glycoprotein IIb/IIIa inhibitors on bleeding events after successful resuscitation and percutaneous coronary intervention | |
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering | |
Is delirium a specific complication of viral acute respiratory distress syndrome? | |
Lethal pulmonary hemorrhage syndrome due to Leptospira infection transmitted by pet rat | |
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense | |
Lysophosphatidylcholine is a major component of platelet microvesicles promoting platelet activation and reporting atherosclerotic plaque instability | |
Macrophages in atheromatous plaque developmental stages | |
Magnetic resonance imaging for pathobiological assessment and interventional treatment of the coronary arteries | |
Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis | |
mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction | |
Mitochondrial mechanisms in septic cardiomyopathy | |
Monocyte dysfunction detected by the designed ankyrin repeat protein F7 predicts mortality in patients receiving veno-arterial extracorporeal membrane oxygenation | |
Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation | |
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe–/– mice | |
Outcomes of female and male patients suffering from coronary artery disease : a nation-wide registry of patients admitted as emergency | |
P2Y12 inhibition in murine myocarditis results in reduced platelet infiltration and preserved ejection fraction | |
P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells | |
Peripheral serotonin lacks effects on endothelial adhesion molecule expression in acute inflammation | |
Platelet contributions to myocardial ischemia/reperfusion injury | |
Platelets, haemostasis and inflammation | |
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile | |
Prolonged SARS‐CoV‐2 shedding and mild course of COVID‐19 in a patient after recent heart transplantation | |
Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS | |
Segmental myocardial velocities in dilated cardiomyopathy with and without left bundle branch block | |
Semaphorin 3F Promotes Transendothelial Migration of Leukocytes in the Inflammatory Response After Survived Cardiac Arrest | |
Serotonin: a platelet hormone modulating cardiovascular disease | |
Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study | |
Severe eosinophilic myocarditis associated with modafinil in a patient with normal peripheral eosinophil count | |
Severe mitral regurgitation requiring ECMO therapy treated by interventional valve reconstruction using the MitraClip. | |
Sex-Specific Differences in Outcome of Transcatheter or Surgical Aortic Valve Replacement | |
Shear Wave Elastography of Peripheral Muscle Weakness in Patients with Chronic Congestive Heart Failure | |
Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN Study | |
SIRT3 deficiency impairs mitochondrial and contractile function in the heart. | |
SIRT3 in Cardiac Physiology and Disease | |
Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis | |
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. | |
Standard operating procedure in patients with severe sepsis and septic shock | |
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. | |
Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin | |
Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo | |
Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction | |
Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression | |
[Successful lysis therapy in acute unilateral renal vein thrombosis] | |
Successful therapy of ventricular rupture by percutaneous intrapericardial instillation of fibrin glue: a case report | |
Suicide attempt by intravenous injection of gasoline: a case report | |
Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. | |
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial | |
Systemic application of anti-ICAM-1 monoclonal antibodies to prevent restenosis in rabbits: an anti-inflammatory strategy. | |
Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation | |
Targeting of single-chain urokinase plasminogen activator by conjugation to an antiplatelet antibody results in enhanced clot lysis | |
Therapeutic inhibition of platelets in acute coronary syndrome and in coronary intervention: mechanisms and clinical results | |
Therapeutic Inhibitors of Platelet Aggregation – from Aspirin to Integrin Blockersf | |
Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis | |
Thrombolytic therapy in acute myocardial infarction--update 1996. | |
Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19 | |
Time course of red cell volume and plasma volume over six months in compensated chronic heart failure | |
Time matters in patients undergoing extracorporeal cardiopulmonary resuscitation. | |
Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial | |
TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation | |
Transapical aortic valve replacement versus surgical aortic valve replacement: A subgroup analyses for at-risk populations | |
[Transcatheter aortic valve implantation and internal carotid artery stenting in a 74-year-old female patient] | |
Transcatheter valve-in-valve implantation in degenerated aortic bioprostheses: are patients with small surgical bioprostheses at higher risk for unfavourable mid-term outcomes? | |
Transesophageal real-time three-dimensional echocardiography methods and initial in vitro and human in vivo studies. | |
Transgenic LQT2, LQT5 and LQT2-5 rabbit models with decreased repolarisation reserve for prediction of drug-induced ventricular arrhythmias | |
Treatment of a broncho-esophageal fistula complicated by severe ARDS | |
Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry | |
Triple antithrombotic therapy in cardiac patients: more questions than answers | |
Triple orifice as a novel strategy in interventional reconstruction of a mitral pseudo cleft. | |
Tumor necrosis factor receptor-associated factor 1 | |
Unprotected left main percutaneous coronary intervention in acute coronary syndromes with extracorporeal life support backup | |
Untersuchungen in vitro über den Stoffwechsel der Serum-high-density-Lipoproteine in Rattenhepatozyten und Fibroblasten normaler und familiär hypercholesterinämischer Individuen | |
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study | |
Usefulness of Rivaroxaban for secondary prevention of acute coronary syndrome in patients with history of congestive heart failure (from the ATLAS-ACS-2 TIMI-51 trial) | |
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation | |
Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: A secondary data analysis of electronic health records | |
The vulnerable myocardium. Diabetic cardiomyopathy | |
Was ist bei Frauen anders? koronare Herzkrankheit |